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X-linked sideroblastic anemia with ataxia 
(XLSA/A) is a rare inherited disorder 
characterized by mild anemia and ataxia. 
XLSA/A is caused by mutations in the ABCB7 
gene, which encodes a member of the ATP-
binding cassette transporter family. Studies in 
yeast, mammalian cells and mice have shown 
that ABCB7 functions in the transport of iron-
sulfur (Fe-S) clusters into the cytoplasm. To 
further investigate the mechanism of this 
disease we have identified and characterized 
the Caenorhabditis elegans homologue of the 
ABCB7 gene, abtm-1. We have studied the 
function of abtm-1 using mutants and RNAi. 
abtm-1 depleted animals produce arrested 
embryos which have morphogenetic defects 
and unusual premature, putative, apoptotic 
events. abtm-1(RNAi) animals also show 
accumulation of ferric iron and increased 
oxidative stress. Despite the increased level of 
oxidative stress in abtm-1(RNAi) animals they 
have increased life-span. We observe 
accumulation of DAF-16/FOXO in the nuclei 
of affected animals, and elevation of the 
expression of SOD-3, a well-established target 
of DAF-16, which may explain the increased 
lifespan extension of these animals. abtm-1 is 
strongly expressed in tissues with a high-
energy demand and abtm-1(RNAi) animals 
have phenotypes that reflect the need for 
abtm-1 in these tissues. Finally we show that 
reducing the function of other genes involved 
in Fe-S cluster production produces similar 
phenotypic consequences to abtm-1 loss of 
function. Therefore, ablation of abtm-1 in C. 
elegans provides a model in which to 
investigate the mechanism underlying 
XLSA/A. 
INTRODUCTION 
X-linked sideroblastic anemia with ataxia 
(XLSA/A; OMIM: #301310) is a rare inherited 
disorder in which male patients suffer from mild 
anemia together with a non-progressive and 
early-onset ataxia characterized by dysmetria, 
and dysdiadochokinesis (1). Other reported 
symptoms include dysarthria, intention tremor, 
mild learning disability and depression. XLSA/A 
associated anemia is mild and asymptomatic in 
males. Female carriers do not, usually, show 
anemia or neurological conditions. XLSA/A is 
caused by mutations in ABCB7, a gene located at 
position Xql3 (2). ABCB7 encodes, a highly 
conserved, protein belonging to the ABCB 
family of ATP-binding cassette (ABC) 
transporters (3). Members of the ABC 
superfamily are transmembrane proteins which 
use the hydrolysis of ATP to facilitate transport 
of a range of substrates across membranes.  
Analyses of three different families with 
XLSA/A have identified three associated 
mutations in the ABCB7 gene. Two of these are 
missense mutations, which cause the substitution 
of residues within the ABCB7 transmembrane 
domains: V411L (4), I400M (2). The third 
mutation produces a more substantial amino acid 
change, E433K (5). A human cDNA containing 
the E433K change is able to partially rescue 
yeast carrying a mutation in ATM1, the 
homologue of ABCB7, suggesting that this 
change does not cause a complete loss of 
function (5). Thus no complete loss of function 
mutations in this gene have been described, 
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suggesting that ABCB7 is an essential molecule. 
In support of this suggestion, ABCB7 knock out 
stem cells, hemizygous mice and mice with 
conditional knock outs in the central nervous 
system or bone marrow are all inviable (6,7). 
Studies in yeast have shown that Atm1p 
localizes to the mitochondrial inner membrane 
and it has been suggested that this molecule is 
involved in the transport of iron-sulfur (Fe-S) 
clusters from the lumen of mitochondria to the 
cytosol (8,9). Moreover, work performed with 
conditional knock out ABCB7 mice suggests that 
mammalian ABCB7 transporters are also 
involved in Fe-S cluster assembly (6). Thus 
mammalian (10) and yeast (8) ABCB7/ATM1 
deficient cells show mitochondrial iron 
accumulation presumably because Fe-S clusters 
cannot be transferred to the cytosol. It is believed 
that this accumulation of mitochondrial iron 
causes oxidative stress, probably by the catalytic 
production of hydroxyl radicals, which then react 
with other biologically important molecules, such 
as proteins, lipids or DNA. This mitochondrial 
stress may then cause cellular dysfunction in the 
nervous system of patients. In addition, the 
impairment of iron homeostasis due to a lack of 
ABCB7 activity, directly or indirectly, disrupts 
the heme synthesis pathway, since Fe-S cluster 
assembly is essential for heme production (11), 
and it is this change which is responsible for the 
anemia of XLSA/A patients (7). Therefore, 
XLSA/A is a mitochondrial disease caused by a 
mutation of a nuclear gene involved in Fe-S 
cluster biosynthesis. 
In this study we used Caenorhabditis elegans 
to establish a model for the investigation of the 
molecular basis of XLSA/A. To do this, we have 
investigated the effect of depletion of abtm-
1/ABCB7 using mutant worms and by RNAi. We 
report, that reduction of abtm-1 function causes 
embryonic lethality during morphogenesis. We 
show that there is premature, putative, apoptosis 
in abtm-1(RNAi) embryos which, compromises 
the development of some cell lineages and may 
thus account for the increased embryonic 
lethality. abtm-1(RNAi) animals that reach 
adulthood show evidence of increased oxidative 
stress and accumulate ferric iron (Fe3+), which 
may produce free radicals. We have also found 
that abtm-1(RNAi) worms have a pattern of 
alterations in lifespan, defecation, motility and 
other behaviors indicative of mitochondrial 
impairment. We show increased expression of 
SOD-3 (superoxide dismutase), a well-known 
DAF-16/FOXO target, and nuclear localization 
of DAF-16/FOXO in abtm-1(RNAi) animals. 
These adaptations to stress may account, 
partially, for the observed lifespan extension. 
Analysis of the expression pattern of abtm-1 
shows that the gene is strongly expressed in 
tissues that are likely to have a high demand for 
ATP. We also show that ablating other 
components of the Fe-S cluster synthesis 
pathway recapitulates some of the phenotypes 
observed in abtm-1 deficient animals. 
EXPERIMENTAL PROCEDURES 
Isolation of the abtm-1 cDNA-To identify the 
5′ end of the cDNA, we used the sequence of the 
spliced leader, SL1, as a forward primer, and a 
gene-specific oligonucleotide as the reverse 
primer. The 3′ end was determined using 3′-
RACE. Both products were cloned into pGEM-T 
(Promega, Madison, Wisconsin, USA) and 
sequenced. We used primers designed using the 
information obtained from these clones to 
amplify the full-length cDNA. All products were 
cloned and sequenced, to obtain the whole 
structure of abtm-1. The coding sequence of the 
gene does not differ significantly from the 
predicted spliced gene in the WormBase (release 
WS181) (NCBI accession number AF490975) 
(Figure S1A). 
Worm culture and strains-Worms were 
cultured using standard techniques and media 
(12). Strains used in this work are listed in Table 
S2. We out-crossed abtm-1(tm2721), a gift from 
S. Mitani, four times before any phenotypic 
analysis was performed. After outcrossing, abtm-
1(tm2721) males were crossed to KR344, which 
carries the free duplication sDp2. F2 
hermaphrodites carrying sDp2 and tm2721 in 
homozygosis were isolated. All strains were 
maintained at 20°C, unless otherwise stated.  
Construction of transgenic worms-We used a 
PCR based fusion approach to make abtm-
1::GFP constructs. Both constructs also contain 
the 3' UTR from unc-54. To produce the 
mitochondrial construct, abtm-1::GFP1, we 
fused a region containing the putative promoter 
and the first three exons of the abtm-1 gene to 
GFP (Figure 1A). The primers used were; 
forward primer FP1175: 5' CTC ACG ATT GAA 
ACG GAC CCG, reverse primer FP784: 5' AGT 
CGA CCT GCA GGC ATG CAA GCT TAC 
TTG ACT ACT GGC TCC CGG. The peptide 
produced by this construct contains the putative 
mitochondrial signal peptide. To obtain the 
cytoplasmic construct, abtm-1::GFP2 (Figure 
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1A), we amplified the region contained between 
the upstream gene, eif-3, and the first codon of 
abtm-1 (forward primer FP1178: 5' CCT ATT 
TTT GAA GGT TTC TGC G; reverse primer 
FP814: 5' AGT CGA CCT GCA GGC ATG 
CAA GCT CAT TAT CGA TCT CTG AAA 
ACT GGA TTC GG). Both reverse primers used 
to make the constructs contain a sequence which 
overlaps the GFP sequence, to allow fusion by 
PCR. To obtain transgenic animals, we injected 
1-2 ng/μl of the test DNA together with 60 ng/μl 
of pRF4 as a marker, and 60 ng/μl of genomic 
DNA from wild type worms, digested with XhoI, 
as a DNA carrier, using methods described 
before (13). 
Cellular localization of ABTM-1-
Hermaphrodites carrying extrachromosomal 
arrays containing abtm-1::GFP1 were incubated 
at 25ºC for an hour, in 50 μM MitoTracker® Red 
CMXRos (Molecular Probes, Invitrogen Ltd, 
Paisley, UK) and 1.8 mM DAPI (4',6-diamidino-
2-phenylindole), diluted in M9 buffer (12). These 
animals were allowed to recover on fresh NGM 
plates for an hour at 20ºC. Then worms were 
anaesthetized using 20 mM sodium azide in M9 
buffer, and mounted for microscopy on 2% 
agarose pads. Images were acquired using a 
Leica SP5 confocal microscope (Leica 
Microsystems GmbH, Wetzlar, Germany). 
RNA interference-RNAi was carried out by 
injection of dsRNA. dsRNA was synthesized in 
vitro, using template fragments of between 
400bp to 700bp, from the appropriate ORF, 
amplified by PCR using primers described in 
Table S3, and cloned into pGEM-T (Promega). 
dsRNA was made using T7 and SP6 RNA 
polymerases (Ambion, Invitrogen Ltd, Paisley, 
UK) and combining the two single stranded 
molecules, as described before (14). As a control, 
we used dsRNA from the Escherichia coli 
chloramphenicol acetyl transferase (cat) gene. 
Several young adult hermaphrodites were 
injected in the gonads (13). Injected worms were 
transferred after 18 hours and phenotypes 
analyzed in the post-18 hour offspring. 
Phenotypes were scored as described below.  
Analysis of embryonic lethality and larval 
arrest-To investigate embryonic lethality in 
RNAi experiments we collected embryos from 
animals after 24 and 38 hours following the 
injection of dsRNA. Then we removed the 
parents and allowed the embryos to develop fully 
for 24 hours before counting the number of 
arrested embryos and larvae. To investigate 
lethality from mutant strains we did the same, but 
for the entire fertile period of the adults. We used 
10 to 12 parental animals per strain per 
experiment. We considered embryos as arrested 
when they failed to hatch within 24 hours. We 
considered larvae as arrested when they did not 
progress to adulthood within 48 hours of 
hatching. 
To further analyze embryonic development 
embryos were isolated by dissection and then 
mounted in embryo culture medium (15). To 
determine the terminal phenotype embryos were 
left for 18 hours at 20°C. Confocal microscopy 
was performed using a Leica SP5 confocal 
microscope. Embryos for 4D-microscopy 
analysis were prepared as described (16). 8 abtm-
1(RNAi) and 3 wild type embryos were mounted, 
at a very early stage (usually 2 cell stage), and 
the recording of their development was carried 
out at 25ºC for 10 hours at intervals of 60 sec, 
with 25 different focal planes (1 m separation), 
using a Zeiss Axioplan microscope (Carl Zeiis 
STM GmbH, Germany) equipped with Nomarski 
optics adapted as described (16). Cell lineage of 
the recorded embryos was subsequently traced 
using SIMI Biocell (SIMI GmbH, Germany).  
Protein extraction-Worms were collected 
from plates by washing with M9 buffer and 
transferred to screw cap tubes. The tubes were 
shaken, gently, for 20 minutes at room 
temperature to allow digestion of bacteria. 
Worms were collected by sedimentation and 
washed three times with M9 buffer. 5 volumes of 
ice-cold lysis buffer (150 mM NaCl, 50 mM 
Tris-HCl pH 8, 1% Nonidet P40 and protease 
inhibitor cocktail) were added to the worm 
pellets, and the mixture was homogenized using 
glass homogenizer during a 30 minute period to 
allow cuticle breakdown. Lysates were 
centrifuged at 10,000g for 30 minutes and the 
supernatant was collected for use in further 
analysis. Protein concentrations were determined 
by the Bradford method. 
Iron measurement-To determine the iron 
content of the worms we used a BioVision Iron 
Assay Kit (BioVision, Mountain View, USA). 
Protein samples from approximately 3000 atm-
1(RNAi), or cat(RNAi), or frh-1(ok610), or N2 
worms were tested for ferrous (Fe2+), ferric (Fe3+) 
and total (Fe2+ + Fe3+) iron following the 
manufacturer’s instructions.  
Oxidative stress assays-To measure 
sensitivity to oxidative stress 80 abtm-1(RNAi) or 
cat(RNAi) L4 larvae were incubated in the 
presence of 0, 0.5, 5 and 10 mM of paraquat 
(methyl viologen, Sigma-Aldrich, St. Louis, 
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USA). The experiments were carried out for 3 
days at 25°C, as described previously (17). We 
scored worm survival each day, using the same 
protocol as for lifespan assays.  
To analyze protein carbonylation we used an 
Oxyblot™ Protein Oxidation Detection Kit 
(Millipore, Billerica, USA). Briefly, worm lysate, 
prepared as above, containing 15 µg of protein 
was incubated in 12% SDS supplemented with 
2.4-dinitrophenylhydrazine (DNPH) for 10 
minutes at room temperature. Samples were 
resolved on a 12% SDS-polyacrylamide gel 
electrophoresis and DNP-derivatized proteins 
were detected by inmunoblot using an anti-DNP 
antibody.  
In vivo analysis of sod-3 and daf-16 
reporters-sod-3 expression was analyzed using 
the KN259 (huIs33[sod-3p::sod-3::GFP + 
pRF4(rol-6(su1006)]) reporter strain. To 
quantify sod-3::GFP expression we collected 
fluorescence images of more than 30 animals for 
each condition (abtm-1(RNAi) or cat(RNAi)). We 
then measured the pixels produced by 
fluorescence in the whole body of animals and 
determined the fluorescence level relative to 
worm area, using ImageJ. To investigate the 
cellular localization of DAF-16 we used the 
strain TJ365 (zIs356[daf-16p::daf-16::GFP; rol-
6(su1006)]). We analyzed control and abtm-
1(RNAi) young adults produced by independently 
injected hermaphrodites (number of observed 
animals per strain 300). We observed the 
worms under a dissecting microscope, equipped 
with fluorescence. Animals were kept on plates 
with food, at 20ºC, and positives were scored 
when the animals presented fluorescent nuclei in 
one or more tissues. As a positive control we 
used animals under starving conditions.  
Lifespan assays-To measure lifespan L4 
larvae were cultured at 20°C on NGM with 
0.1g/ml of 5-fluorodeoxyuridine (Sigma-Aldrich) 
until death. Death was assessed by the animal’s 
response to gentle nose touch. Worm survival 
was counted every 24 hours. Missing worms 
were scored as censored data. We scored more 
than 200 worms per sample.  
Statistical analyzes-All data are presented as 
means ± standard error of the mean, or as % of 
population. To assess statistical significance we 
compared different populations using Student's 
two-tailed t-test using GraphPad online 
(http://www.graphpad.com). To compare 
survival curves from lifespan and oxidative stress 
assays we used the Log-rank (Mantel-Cox) Test, 
contained within the GraphPad Prism software 
(GraphPad Software, Inc. La Joya, USA). 
RESULTS 
The C. elegans ABCB7 homologue, ABTM-1, 
is a mitochondrial protein which is highly 
expressed in mitochondria rich tissues-To 
identify homologues of ABCB7 in C. elegans, 
we used the human ABCB7 (hABCB7) sequence 
to search the C. elegans genome. We found that 
abtm-1 (Y74C10AR.3) (Figure 1A) shows high 
similarity to hABCB7. We cloned the abtm-1 
cDNA using RT-PCR. The abtm-1 cDNA is 
2504bp long (Figure S1A), and encodes a 
predicted protein of 703 residues. The C-terminal 
region of the predicted peptide, ABTM-1, is 51% 
identical to hABCB7 (Figure S1B). ABTM-1 has 
the typical ABC superfamily structure, with six 
transmembrane domains and an ATP binding 
domain (Figure S1B). Alignment of the protein 
sequence with sequences from the human and 
yeast ABCB7 family shows that ABTM-1 
clusters within this family (Figure S1C), strongly 
suggesting that this protein belongs to the 
ABCB7 transporter group. Analysis of ABTM-1 
using the Mitoprot program (18), gave a 
probability of 99.4% that ABTM-1 is 
mitochondrial. To demonstrate that ABTM-1 is 
indeed a mitochondrial protein we produced 
transgenic animals carrying an abtm-1::GFP 
fusion (abtm-1::GFP1, Figure 1A) in which GFP 
is fused to the end of the third exon of abtm-1. 
The predicted peptide should contain the first 67 
amino acids of the protein, including the 
predicted mitochondrial localization signal. We 
incubated transgenic worms carrying abtm-
1::GFP1 with a mitochondrial marker, 
MitoTracker® Red CMXRos (Molecular Probes). 
Confocal microscopy of these worms shows that 
ABTM-1::GFP1 clearly co-localizes with the 
mitochondria marker (Figure 1B) confirming that 
ABTM-1 is a mitochondrial protein and the C. 
elegans homologue of hABCB7. 
We sought to investigate the expression 
pattern of abmt-1 using the abtm-1::GFP1 
fusion, however this construct resulted in some 
toxicity (data not shown). We therefore produced 
a cytoplasmatic GFP construct, abtm-1::GFP2, 
in which the first codon of abtm-1 was fused to 
GFP (Figure 1A). Transgenic animals containing 
abtm-1::GFP2 show widespread expression in 
the tissues of adult hermaphrodites including the 
intestine, spermatheca, epidermis and 
coelomocytes, amongst others (data not shown). 
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Interestingly, abtm-1::GFP2 is highly expressed 
in tissues that are predicted to require high levels 
of energy production such as pharyngeal muscles 
(Figure 1Ci), neurons (Figure 1Ci), developing 
embryos (Figure 1Cii), and body wall muscles 
(Figure 1Ciii), amongst others.  
Worms carrying a deletion in abtm-1 are not 
viable-We obtained a strain carrying a deletion 
and, probable, null allele of abtm-1, abtm-
1(tm2721) (Figure 1A). The tm2721 allele was 
out-crossed and balanced with sDp2, a 
duplication of the region of chromosome I 
carrying the abtm-1 gene thus, allowing us to 
maintain tm2721. sDp2 is a free duplication that 
undergoes random, non-Mendelian segregation 
with either copy of chromosome I during meiosis 
(19). Hermaphrodites carrying mutations that 
map in the region balanced with sDp2 segregate, 
about 38% unbalanced mutant homozygotes (19). 
We isolated and analyzed three abtm-1(tm2721)I; 
sDp2(I;f) strains from independent crosses. We 
were unable to isolate viable homozygous 
unbalanced animals from these strains. We 
observed that the balanced animals produced 
28.1%±1.1 arrested embryos, and 7.1%±0.6 
arrested L1-L2 larvae (wild type 1.2%±0.2 and 
0% arrested embryos and larvae). The total 
lethality is therefore 35.2%, which is close to the 
predicted value of 38% for homozygous animals. 
This experiment strongly suggests that abmt-
1(tm2721) homozygous animals exhibit early 
lethality and are unable to develop to adulthood.  
RNAi of abtm-1 induces embryonic arrest 
during late embryogenesis-Since complete 
ablation of abtm-1 is lethal, we sought to emulate 
the condition of XLSA/A patients by reducing, 
rather than completely removing, the function of 
the abtm-1 gene. To do this we used RNAi 
(abtm-1(RNAi)). We injected double-stranded 
abtm-1 RNA into young wild type 
hermaphrodites to induce RNAi and then 
examined the resulting offspring. In agreement 
with results obtained using abmt-1(tm2721) 
embryos, we observed that reducing ABTM-1 in 
wild type hermaphrodites induce embryonic 
arrest in their offspring, 28%±1.24 (Figure 2A). 
This lethality is further increased to 56%±2.7 in 
daf-16/FOXO mutants (Figure 2A). DAF-16 is 
widely involved in insulin signaling and stress 
responses in C. elegans (20). Thus daf-16 can 
protect against abtm-1(RNAi) induced lethality, 
suggesting that the lethality may result from 
increased stress of some kind. 
To further analyze the nature of the defects 
in abtm-1(RNAi), we observed them under a DIC 
microscope. Some abtm-1(RNAi) embryos, 7.7%, 
arrested during the early proliferative stages 
(Figure 2B), however, most of the arrested 
embryos showed clear signs of cell 
differentiation (Figure 2C). For example, abtm-
1(RNAi) embryos had gut granules indicating that 
the intestinal cells had differentiated (Figure 
2Cii) and also showed vigorous twitching, an 
indicator of muscle cell differentiation. As the 
embryos arrested after gastrulation, we analyzed 
the behavior of epidermis, which plays a major 
role during embryonic morphogenesis (21,22). 
To do this we used an epithelial cell-specific 
marker, ajm-1::GFP (22). 92.3% of arrested 
abtm-1(RNAi) embryos showed correctly (i.e. 
apically) localized AJM-1::GFP (N=104) (Figure 
2Cii-iv), suggesting that the epidermal cells are 
also differentiated. Nevertheless analysis of the 
pattern of AJM-1::GFP, revealed that most 
embryos show a highly disorganized structure, 
including a retracted epidermis (Figure 2Cii-iii), 
and the presence of internal tissues on the 
exterior of the embryo (Figure 2Cii). Therefore, 
ABTM-1 is required for appropriate embryonic 
morphogenesis in C. elegans. 
abtm-1(RNAi) embryos have premature, 
putative apoptotic events-To investigate possible 
causes of the morphogenetic defects in abtm-
1(RNAi) embryos we used 4D video microscopy 
and lineage analysis. The cell lineage of C. 
elegans is well defined so that every somatic cell 
can be traced (16). Moreover, 4D imaging is a 
well established tool for identifying and studying 
apoptosis (23,24). In a wild type embryo the 
progeny of the “founder cell” AB (the anterior 
cell in the 2 cell stage embryo) divide, in near 
synchrony, after each cell generation and can be 
readily tracked by 4D video microscopy imaging. 
We recorded abtm-1(RNAi) and wild type 
embryos to identify differences in cell cycle 
length, fate specification, morphogenesis and cell 
death. Six of the abtm-1(RNAi) embryos were 
analyzed in detail with respect to cell lineage and 
timing. We observed four phenotypic classes of 
abtm-1(RNAi) embryos (Table 1). abtm-1(RNAi) 
embryos have delayed cell divisions, cells which 
are excluded from the embryo and in extreme 
cases burst. In addition two of the embryos 
showed a striking defect. Some cells in the 9th 
cell generation (ABalaaapp, ABprappap and 
ABprppapa in one embryo, and most probably 
ABplpppapp in the other) underwent cell death, 
most probably by apoptosis (Figure 2D). In 
normal embryos apoptosis occurs in specific cells 
in the 10th and the 11th cell generation, as a 
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consequence of specific cell fate decisions. The 
presence of these putative premature apoptotic 
events may indicate that cells are activating the 
apoptotic pathway as consequence of cellular 
stress. abtm-1(RNAi) embryos also show 
increases in the cell cycle length (Table 1). The 
severity of this defect increases as development 
proceeds with late cells dividing much more 
slowly than the early blastomeres. On average 
the division of ABxxxxxx, the last cell division 
recorded was nearly twice as long as the wild 
type division and in extreme cases was nearly 
three times as long (Table 1). Again this suggests 
that cellular metabolism is disrupted. In addition 
in three embryos some cells were excluded from 
the body during morphogenesis (Figure 2Dii). 
4D analysis, in one embryo clearly identified 3 
out of 10 of these cells as neuronal cells of the 
ring ganglion (the specific cells are 
ABalapappap, ABalappaapa, ABalapppaap).  
abtm-1(RNAi) animals show accumulation of 
Fe3+-Our results above suggest that abtm-1 
animals have severe cellular defects. We sought 
to determine whether those abtm-1(RNAi) 
animals that reach adulthood have changes in 
their physiology reflecting the function of 
ABTM-1. Deletion of the yeast ABCB7 
homologue, ATM1 (8), results in ferric iron 
(Fe3+) over-load. We therefore hypothesized that, 
if abtm-1 function is conserved in C. elegans, 
abtm-1 knock-down should lead to a similar 
phenotype. To test this hypothesis we sought to 
measure iron levels in abtm-1 depleted animals. 
We also tested frh-1(ok610) worms which carry a 
loss of function allele in the frataxin (frh-1) gene 
(17), responsible of Friedreich’s ataxia (25). This 
molecule has been suggested to be involved in 
Fe-S cluster synthesis (reviewed by Stemmler et 
al., (26)), amongst other hypothesis (reviewed by 
Gonzalez-Cabo et al., (27)). Disruption of 
frataxin induces iron accumulation in many 
organisms, for example in yeast (28). Although 
total iron levels (Fe2+ + Fe3+) in abtm-1(RNAi) 
animals did not show any significant difference 
to control animals, abtm-1(tm2721)/+ mutants 
showed a sensible increase (n≥3000 for each 
strain tested) (Figure 3A). In both cases Fe3+ was 
present at much increased levels in abtm-1(RNAi) 
(10 fold), abtm-1(tm2721)/+ (16 fold) and also in 
frh-1(ok610)/+ (18 fold) animals compared to 
wild type and cat(RNAi) controls (Figure 3B). 
Depletion of abtm-1 causes increased 
oxidative stress but extended lifespan-As abtm-
1(RNAi) animals show accumulation of Fe3+ we 
sought to investigate if this caused increased 
oxidative stress. First we tested the ability of 
abtm-1(RNAi) animals to cope with an externally 
induced increase in free radicals by measuring 
survival on exposure to paraquat (29,30). Worm 
survival in the presence of a range of paraquat 
concentrations was measured. On 0 and 0.5 mM 
paraquat the survival of abtm-1(RNAi) animals is 
unaltered (data not shown). However, at 5 and 10 
mM paraquat abtm-1(RNAi) worms show 
substantial reductions in survival (Log-rank 
(Mantel-Cox) test p<0.0001 for both paraquat 
concentrations) (Figure 4A), suggesting that 
reductions in ABTM-1 cause increased 
sensitivity to oxidative stress. 
We next examined whether abtm-1(RNAi) 
animals had increased levels of endogenous free 
radicals. We examined the expression of a sod-
3::GFP reporter gene. SOD-3 is a mitochondrial 
manganese-dependent superoxide dismutase 
homologue and a known free radical scavenger. 
Expression of sod-3::GFP transgenes is known 
to be increased in response to increases in free 
radical production (31). abtm-1 RNAi on animals 
carrying the sod-3::GFP transgene, resulted in a 
greater than two fold increase in fluorescence 
compared to controls (P<0.001; N=30), (Figure 
4B).   
To confirm that ablation of abtm-1 induces 
oxidative stress we sought to investigate the 
effects of increased free radical levels in vivo. 
Thus we measured protein carbonylation as 
amino acid carbonylation is caused by free 
radicals. To do this we used an OxyblotTM assay 
on abtm-1(RNAi), wild type and cat(RNAi) 
worms, together with frataxin mutant animals. 
cat(RNAi) and wild type worms show similar 
amounts of carbonylated proteins (Figure 4C; 
lanes 1 and 2), while the frataxin worms show an 
increase of 1.5 fold (Figure 4C; lane 4). 
Interestingly, the abtm-1(RNAi) worms show a 
3.5 fold increase in carbonylated proteins (Figure 
4C; lane 3). Thus the above evidence all suggests 
that abtm-1 depleted animals are under 
significantly increased levels of oxidative stress, 
presumably resulting from increased Fe3+ levels. 
abtm-1(RNAi) animals have increased 
lifespan, which is partially dependent on daf-
16/FOXO-Increased oxidative stress might be 
expected to reduce life span. However, the life 
span of abtm-1 deficient worms is significantly 
increased compared to control animals (abtm-
1(RNAi) (median lifespan (ML)=23 days vs 
cat(RNAi) ML=19 days, p<0.0001; Table S1), 
(Figure 5A). Changes in the activity of the 
transcription factor daf-16/FOXO alter longevity 
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in many organisms, including humans (32). 
Further, daf-16 is known to mediate both insulin 
and stress responses (20). Therefore we tested for 
interactions between the effects on lifespan of 
abtm-1 and daf-16. Interestingly, depletion of 
abtm-1 in a daf-16 loss of function background 
shows a partial increase in lifespan (Figure 5A) 
(daf-16(mu86); abtm-1(RNAi) ML=18 daf-
16(mu86); cat(RNAi) ML=17; Table S1), 
suggesting that the lifespan increase in abtm-
1(RNAi) animals is partially dependant on DAF-
16 function.  
DAF-16 is known to relocate from the 
cytoplasm to the nucleus when activated (33). 
Therefore we investigated the cellular 
localization of DAF-16 in abtm-1 depleted 
worms, by inducing abtm-1 RNAi in animals that 
carry a functional DAF-16::GFP fusion (33). We 
observed that most abtm-1(RNAi) animals 
showed nuclear localization of DAF-16 in one or 
more tissues, suggesting that ablation of abtm-1 
induces signals that activate DAF-16. 
abtm-1 depleted adult animals have a 
pleiotropic phenotype including defects in  
locomotion and rhythmic behavior-Phenotypic 
analysis of adults (and embryos) is a prerequisite 
to our aim of establishing a model for XLSA/A 
which can be used for both mechanistic studies 
and screening for compounds that may be 
developed for clinical use. In C. elegans, 
mitochondrial mutants (Mit mutants) usually 
show a range of phenotypes, including 
developmental, physiological and behavioral 
defects (reviewed by Tsang and Lemire (34)). 
This is indeed the case of abtm-1(RNAi) worms, 
which show a pleiotropic phenotype that includes 
developmental defects, growth, egg laying, 
ultradian rhythms (35) and locomotion defects 
(see above and Supplemental Material).  
Therefore abtm-1(RNAi) show similar traits to 
other Mit mutants. 
Disruption of other components of the Fe-S 
cluster biosynthesis pathway induces similar 
phenotypes to depletion of abtm-1-In yeast 
cytosolic Fe-S clusters are produced exclusively 
in the lumen of mitochondria. Fe-S clusters are 
produced using sulfur from cysteine in a reaction 
catalyzed by cysteine desulfurase (Nfs1p). 
Production also requires chaperones and scaffold 
proteins (Isa1p, Isa2p, Isu1p, and Isu2p), and 
red-ox proteins (Arh1p, Yah1p and 
Glutaredoxin-5), which supply Fe2+ (reviewed in 
(36,37)). Once produced, Fe-S clusters are either 
used in mitochondrial Fe-S-containing proteins 
or they are transported to the cytosol, by means 
of Atm1p/ABCB7, where they are used to 
produce cytosolic Fe-S-containing proteins (36)  
(Figure 6). We investigated whether disrupting 
other steps in Fe-S synthesis would phenocopy 
the traits described above for abtm-1(RNAi) 
animals. We performed RNAi on the C. elegans 
orthologues of six Fe-S cluster biosynthesis 
genes (Wormbase release WS185, 
www.wormbase.org) (Table 2 and Figure 6). 
Knocking down these genes produces a range of 
phenotypes (e.g. disrupted defecation, extended 
lifespan, larval arrest) all compatible with a Mit 
phenotype (Table 2). Moreover, in all six cases, 
depletion produce significant embryonic arrest 
showing that disrupting the Fe-S cluster pathway 
compromises embryonic development in C. 
elegans. Both the Mit phenotype and embryonic 
lethality recapitulate the phenotypes produced by 
ablation of abtm-1. 
DISCUSSION 
XLSA/A is an untreatable disease caused by 
mutations in the ABCB7 gene.  ABCB7 is 
believed to function in the mitochondrial 
transport of Fe-S clusters into the cytoplasm 
(8,9). It is thought that defective Fe-S cluster 
transport leads to mitochondrial iron overload 
with subsequent free radical production, and to 
reduced heme synthesis which in turn results in 
reduced Fe-S-containing enzyme activity. These 
deficits may then lead to mitochondrial 
dysfunction and to the pathology of XLSA/A 
(11). Thus XLSA/A is one of a growing number 
of mitochondrial diseases (38,39). Using mutants 
and RNAi we analyzed the effects of total and 
partial loss of function in abtm-1, the C. elegans 
homologue of ABCB7. Complete loss of abtm-1 
function is lethal, as is the loss of ABCB7 in mice 
(6) and partial loss of function also leads to a 
substantial level of embryonic and larval arrest. 
Thus, as in other systems, ABCB7/abtm-1 is an 
essential gene. The use of RNAi enabled us to 
produce a model which recapitulates the partial 
loss of function found in XLSA/A patients. 
Partial loss of function results in arrested 
embryos and adults with increased Fe3+ levels, 
higher oxidative stress, increased lifespan and a 
range of phenotypes characteristic of mutations 
which cause mitochondrial dysfunction. 
Expression analysis showed that ABTM-1 is a 
widely expressed mitochondrial protein that it is 
produced at particularly high levels in tissues 
which are expected to have high energy 
requirements, as is the case in humans and mice 
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(3,6). Thus our data show that, as in other 
models, abtm-1 is an essential mitochondrial 
gene.  
Depletion of abtm-1 caused substantial 
embryonic arrest. Analysis of abtm-1(RNAi) 
embryos showed that arrest mostly occurs after 
the initial proliferative phase and usually during 
morphogenesis. Detailed analysis of early 
embryonic development, using 4D imaging, 
showed that the embryos have slower cell 
divisions and that, strikingly, they exhibit 
putative premature apoptosis. These early defects 
may underlie later defects in morphogenesis. For 
example the loss of cells due to putative 
apoptosis could result in the loss of cells or cell 
types which are required for morphogenesis. In 
particular the putative apoptotic cells observed in 
the abtm-1(RNAi) embryos, belong to lineages 
that will give rise to neuroblasts, a cell type 
which is essential for proper epidermal migration 
during morphogenesis (21). In addition, 
disorganized cell division may result in the 
failure of important inductive developmental 
signaling events in the early embryo, again 
leading to the loss of particular cells and cell 
types. The early defects in these embryos could 
all result from an abnormal mitochondrial 
function. For example, apoptosis may result from 
defective mitochondrial function (40). Similarly 
the cell cycle has a high energy demand (41) and 
may be retarded due to reduced ATP levels 
caused by poor mitochondrial function. 
Interestingly, a delay in cell cycle progression 
has been described in Drosophila as a result of a 
mutation in tenured, a gene encoding 
mitochondrial cytochrome oxidase subunit Va 
(42). Thus defects in abtm-1 may cause lethality 
in embryos due to a pyramid of effects, which 
emanate from mitochondrial dysfunction.  
Although depletion of abtm-1 by RNAi 
produced substantial lethality, a significant 
proportion of worms were able to survive to 
adulthood. This presumably reflects different 
degrees of abtm-1 depletion in different animals. 
Animals which survived to adulthood 
demonstrated a range of phenotypes including 
disrupted defecation, egg laying and locomotion 
suggesting a widespread perturbation of 
physiological function in several tissues 
including neurons. This range of phenotypes is 
reminiscent of the pleiotropy observed in other 
mitochondrial mutants, such as frh-1, the C. 
elegans homologue of frataxin (17,43). 
Interestingly, the role of frataxin, although still 
controversial (see (27,44,45)), has also been 
linked to Fe-S cluster production (see Rouault 
and Ton for a review (46)). Therefore phenotypes 
caused by depletion of both molecules may be 
due to similar cellular stresses. We propose that 
this pleiotropic phenotype results from defects in 
Fe-S cluster metabolism. In support of this 
depleting other genes involved in Fe-S 
biogenesis and transport results in phenotypes 
that share some of the features of abtm-1(RNAi) 
worms. It is interesting to note that RNAi on four 
of these genes (B0205.6/NFS1, 
Y73F8A.27/YAH1, Y39B6A.3/ISA1 and 
Y45F10D.4/ISU1) produced 100% embryonic 
and larval arrest in the offspring. This may 
reflect a more severe mitochondrial defect in 
these worms, perhaps because they affect key 
steps in the synthesis of all Fe-S clusters in 
contrast to abtm-1 which only mediates transport 
of cytosolic Fe-S clusters. Differences in the 
strength of the RNAi may also explain 
differences in the severity of phenotypes.  
We observed a substantial increase in Fe3+ in 
abtm-1 animals. abtm-1 mutant animals also 
showed an increase in total iron content. 
Disruption of iron homeostasis underlies many 
human disorders. This is probably also the case 
in XLSA/A where it has been suggested that the 
pathological condition may be a consequence of 
mitochondrial iron accumulation. In this regard, 
the yeast mutant atm1∆ shows accumulation of 
ferric phosphate (47). It is suggested that ferrous 
iron (Fe2+) enters mitochondria where it is 
oxidized to Fe3+. Excess ferric iron, due to 
inactivity of ABTM-1, has been shown in 
Atm1/ABCB7 depleted yeast (28,47,48). Thus 
our results are compatible with previous studies.  
abtm-1 animals have increased oxidative 
stress as measured by a number of approaches. 
One implication of the increase in oxidative 
stress might be expected to be a decrease in 
lifespan, however these worms actually have 
increased life span. This paradox may be 
explained by hormesis. In hormesis a beneficial 
biological response in a cell or organism is 
initiated by a non-lethal detrimental stress. The 
response is primarily aimed at counteracting the 
damage produced by that stress, but also results 
in an increased life expectancy. This 
phenomenon has been documented in yeast (49) 
and C. elegans (50,51) and indeed many 
mitochondrial mutants in C. elegans, that do not 
compromise survival, also show lifespan 
extension (10,52). Thus in abtm-1(RNAi) animals 
the activation of scavenging molecules that 
promote cell survival, in response to the 
 9
production of free radicals in mitochondria, may 
in turn increase life span. This may be reflected 
in the nuclear localization of DAF-16 and the 
increased expression of sod-3 both of which are 
markers of increased oxidative stress but are also, 
presumably, protective.  
daf-16 is a master regulator of life- and 
health-span (53) and it is widely implicated in 
stress and related responses.  DAF-16 appears to 
play an important role in the effects of abtm-1 
depletion suggesting that increased stress is a key 
determinant of the effects of abtm-1 ablation, 
probably in response to free radical production. 
Increased nuclear localization of DAF-16 in 
abtm-1(RNAi) worms strongly suggests that it is 
being activated. DAF-16 may in turn induce the 
expression of sod-3, amongst other protective 
genes. The embryonic arrest caused by depletion 
of abtm-1 is enhanced in a daf-16 null 
background, suggesting that the presence of daf-
16 is able to protect against abtm-1(RNAi) 
mediated damage caused by Fe3+ accumulation 
and free radical production. In addition the 
increase in lifespan observed in abtm-1 ablated 
animals is, at least, partially dependent on DAF-
16. This may be explained if the putative 
hormesis discussed above is daf-16 dependant. 
Indeed DAF-16 may act as a mediator of 
hormesis in C. elegans, upon activation by 
cellular stress (54). The increase in lifespan can 
not be completely attributed to the action of 
DAF-16 and its downstream targets, as daf-
16(mu86); abtm-1(RNAi) animals still have an 
increase in lifespan, suggesting that other forms 
of lifespan extension such as mitochondrial 
malfunction (Figure 5C) or calorific restriction 
could be involved. 
Model systems are critical to our ability to 
understand these processes. We have established 
a C. elegans model of the human disease 
XLSA/A. The ability to use a genetically 
tractable metazoan in the study of XLSA/A, and 
other mitochondrial diseases, should improve our 
understanding of the mechanisms that underlie 
these conditions. C. elegans enables the use of 
high throughput automated RNAi screens, using 
for example embryonic lethality, to identify 
genetic interactions (55). C. elegans can also be 
used in high throughput compound screens (56), 
or in the testing of drug candidates such as free 
radical scavenging molecules or activators of cell 
survival pathways that diminish cellular stress. 
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FIGURE LEGENDS 
Figure 1. The abtm-1 gene is the homologue of human ABCB7. A, genomic structure of abtm-1. The 
grey arrow under the gene indicates that abtm-1 is contained within an operon, OP1920, which 
contains another gene, Y74C10AL.2. The red box above the gene shows the position of the deletion 
in abtm-1(tm2721). This diagram also shows the two GFP translational fusions used in this work. 
Blue boxes indicate exons of abtm-1. B, confocal microscope images showing co-localization of 
ABTM-1::GFP with Mitotracker Red, in muscle cells from adult hermaphrodites. C, abtm-1::GFP2 
is highly expressed in the pharynx and neurons of the ventral and dorsal ganglions (i), developing 
embryos (ii) and body wall muscles and epidermis (iii). 
Figure 2. Disruption of abtm-1 produces embryonic lethality, which is further increased by depletion 
of daf-16. A, embryonic lethality in the offspring of abtm-1(RNAi) worms in wild type and daf-
16(mu86) backgrounds. abtm-1(RNAi) hermaphrodites produce 28% dead embryos, whereas 
depletion of abtm-1 in daf-16 mutants produce 56%. B, abtm-1(RNAi) produces arrest of embryos 
mostly during morphogenesis (96%). C, representative examples of abtm-1(RNAi) arrested embryos. 
Ci, transmitted light image of an embryo arrested during the proliferation stage. Cii, confocal image 
of an embryo arrested during morphogenesis, showing signs of cellular differentiation. The yellow 
and white arrows point to AJM-1::GFP expression, a cell specific marker of epithelia, in the 
pharyngeal and epidermal cells respectively. The red arrow indicates autofluorescent granules, 
characteristic of the intestinal cells. Ciii, confocal image of an embryo in which the epidermis has 
failed to migrate during ventral enclosure leaving the embryo incompletely enclosed as indicated by 
the arrow. Civ, an embryo arrested during the last step of morphonegenesis, elongation. The 
epidermis has enclosed most of the embryo, but it is highly disorganized. D, transmitted light 
images, from 4D microscopical analysis. Di, wild type embryo. Dii, embryo arrested during 
morphogenesis showing the presence of internal tissues external to the embryo. Diii-iv, embryos 
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showing premature apoptotic events in the 9th generation. Apoptotic cells are indicated by arrows. 
All scale bars represent 10 µm. 
Figure 3. Depletion of abtm-1 induces accumulation of ferric iron. A, the graph shows total iron 
content, normalized to the wild-type level in wild type, cat(RNAi), abtm-1(RNAi) and frh-1(ok610) 
animals. B, the graph shows the percentage of ferrous and ferric iron in the same strains normalized 
to the total iron content in that strain. Fe3+ is increased in animals with reduced ABTM-1 or frataxin 
(FRH-1).  
Figure 4. abtm-1(RNAi) worms are under oxidative stress. A, survival graphs of wild type, abtm-
1(RNAi) and control animals cat(RNAi) grown in different concentrations of paraquat. At 5 and 10 
mM the survival of abtm-1 depleted animals is significantly lower (p<0.0001 in both cases) than 
control and wild type animals. B, transmission and fluorescent images of representative offspring 
from RNAi treated worms containing the sod-3::GFP construct. abtm-1(RNAi) animals show an 
obvious increase in fluorescence (i.e sod-3 expression) compared to controls. Scale bars represent 50 
µm. Quantification of this increase is shown below where the average fluorescence intensity 
(represented by arbitrary units), relative to the body area of each worm, in sod-3::GFP worms  
plotted. abtm-1 depleted animals show a significant increase of expression compared to control 
worms (p<0.001) (N≥30). C, OxiblotTM assay on cat(RNAi), wild type abtm-1(RNAi) and frh-
1(ok610) animals. Carbonylated proteins were quantified for each lane using Multi-Gauge Software 
(FUJIFILM). To allow for loading variation values were normalized to the actin control. Final values 
are expressed as a percentage of the wild-type value and shown below each lane. It can be seen that 
frh-1(ok610), and the abtm-1(RNAi) worms show a marked increase in carbonylated proteins.  
Figure 5. The lifespan of abtm-1(RNAi) adults is increased, in a partially daf-16–dependent manner. 
A, lifespan curves of abtm-1(RNAi) worms in wild type and daf-16(mu86) mutant backgrounds. The 
lifespan of abtm-1 depleted animals is significantly longer than control worms (p<0.0001). Induction 
of abtm-1 RNAi also increases the lifespan of daf-16(mu86) mutants (p<0.0001), but to a lesser 
extent (also see table S1). B, abtm-1 RNAi induces localization of DAF-16 in the nucleus in some 
tissues in 70% of worms. Starved animals (first bar) were used as positive control, as they show 
strong nuclear DAF-16 localization. 
Figure 6. The Fe-S cluster synthesis pathway and our working model for the lifespan extension and 
apoptotic events caused by depletion of abtm-1 in C. elegans. The diagram shows the ABC 
transporter ABTM-1/Atm1p, and some of the enzymes (ferredoxin reductase: Y62E10A.6/Arh1p, 
and Ferredoxin: Y73F8A.27/Yahp), and scaffolding proteins (LPD-8/Nfu1p, B0205.6/Nfs1p, 
Y39B6A.3/Isa1p and Y45F10D.4/Isu1p) involved in the synthesis of Fe-S clusters. These molecules 
are represented by the name of the protein in C. elegans (bold), and the corresponding S. cerevisiae 
homologue. Defects in Fe-S cluster synthesis caused by abtm-1(RNAi), as indicated by the box 
surrounded by a dotted line, cause accumulation of iron, which in turn induces free radicals. The 
oxidative stress promoted by the free radicals is responsible for mitochondrial damage, which may 
lead to premature apoptosis, and activation of DAF-16. Both, mitochondrial damage and DAF-16 
activation may induce lifespan extension in individuals which survive embryogenesis. The lifespan 
extension induced by DAF-16 may be due to the expression of genes such as sod-3.  
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Table 1. Delayed cell divisions in abtm-1(RNAi) embryosa 
Cycle cell 


















AB - - - - -  
ABx 12.5 - 17 (36%) 19 (52%) 20 (60%) 16.4 (31%) 
ABxx 14.6 - 20 (37%) 21 (44%) 24 (65%) 18.8 (29%) 
ABxxx 16.4 27 (64%) 24 (45%) 24 (46%) 32 (94%) 23.0 (39%) 
ABxxxx 23.9 41 (71%) 33 (37%) 36 (51%) 42 (76%) 33.0 (38%) 
ABxxxxx 25.3 57 (125%) 45 (78%) 47 (86%) 63 (149%) 44.3 (75%) 



















(2)   
a abtm-1(RNAi) embryos were analyzed by 4D video microscopy and subsequent lineage analysis. Embryos were 
divided into 4 types based on the nature of the developmental defects observed. Delays during the development of 
all the embryos were measured, although we only show data of the 4 representative types. Numbers indicate the 
time (in minutes) to complete the cell cycle for the cell in left hand column. Although some variability in the timing 
of cell cleavages occurs from embryo to embryo in the wild type (16), the difference compared to the reference 
published by Sulston in 1983 (16), is always smaller than a 10% of the cell cycle length. We consider that a cell is 
dividing significantly slower than wild type when the length of its cell cycle is at least 20% longer than the wild type 
reference. 
b The increment of the time in delayed cycles is shown in brackets. To obtain the average of the increment we 
included the cycles of all available embryos (N=8).  
c The lower row shows the phenotype for each type of abtm-1(RNAi) embryo. All types showed delayed 
development. Type 1 did not have any other apparent defects. Type 2 embryos had internal tissues on the exterior 
(Gex phenotype). Type 3 embryos burst, probably due to a defect in morphogenesis. Type 4 showed some 
premature apoptosis as well as morphogenetic defects. The number of embryos of each type that we observed is 




















Wild type   2.1 (1597) 0 48±3 (6±1) Normal 
cat(RNAi) naa 1.9 (1641) 0 48±1 (5±1) Normal 
abtm-1(RNAi) ATM1 27.9 (945) <5 60±3 (17±3) 
Long-lived 
(p<0.001)b 
Y62E10A.6(RNAi) ARH1 11.8 (543) <5 77±5 (14±2) 
Long-lived 
(p<0.001)b 
lpd-8(RNAi) NFU1 18.0 (389) <5 50±2 (8±1) 
Long-lived 
(p<0.001)b 
B0205.6(RNAi)  NFS1 39.5 (440) 100 naa naa 
Y73F8A.27(RNAi)  YAH1 48.8 (540) 100 naa naa 
Y39B6A.3(RNAi)  ISA1 63.1 (367) 100 naa naa 
Y45F10D.4(RNAi) ISU1 84.1 (414) 100 naa naa 
a na: not applicable. 
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